Healthy Female Army
No Result
View All Result
  • Healthcare
  • Health and Medicine
  • Health News
  • Staying Healthy
  • Healthcare
  • Health and Medicine
  • Health News
  • Staying Healthy
No Result
View All Result
Healthy Female Army
No Result
View All Result
Home Healthcare

Pfizer sees revenue for COVID products fall, expects new booster authorized this month

by
August 1, 2023
in Healthcare
0
Pfizer sees revenue for COVID products fall, expects new booster authorized this month
0
SHARES
7
VIEWS
Share on FacebookShare on Twitter

The Food and Drug Administration (FDA) could authorize Pfizer’s updated COVID-19 boosters by the end of August, company CEO Albert Bourla said during an earnings call Tuesday.

Still, it’s unclear if there will be widespread demand once the shot hits the market, underscoring softening sales from its portfolio of COVID-19 products. 

“Clearly, there is a higher level of uncertainty regarding the demand projections for our COVID-19 products than for the rest of the business,” Bourla said in the call.

For example, Bourla in January said he expected that approximately 100 million doses of COVID-19 vaccines would be administered in the U.S. this year, 60 percent of which were expected to be Pfizer’s.

But in the first six months of the year, just 12.4 million doses were administered. 

Pfizer reported second-quarter sales of $12.73 billion, down 54 percent from the same period last year.

“The contraction in revenues was driven by the anticipated decline in Paxlovid and Comirnaty sales,” Pfizer’s CFO David Denton said. Comirnaty is the name under which Pfizer’s shot is marketed.

According to the company, its vaccine earned $1.49 billion in sales, down 83 percent from this time last year. The antiviral pill Paxlovid posted $143 million in revenue, a drop of 98 percent.

However, the vast majority of respiratory vaccinations happen during the fall and winter respiratory disease season, which starts in September, “and we expect COVID-19 vaccinations to follow this pattern going forward,” Bourla said.


COVID hospital admissions jump in what could be a new norm of summer surges

Bourla said the second half of the year will also play a bigger role in determining the long-term demand for Paxlovid, use of which follows very closely the COVID-19 infection rates. 

“We expect a new COVID-19 wave to start in the U.S. this fall, and this expectation is supported by the increase in infection rates we are already seeing,” Bourla said.

The federal government is no longer paying for COVID-19 vaccines with the end of the pandemic public health emergency. That means the vaccines are now only available on the commercial market.

The company sells Paxlovid to the government for about $530 for a five-day course of treatment, but it has not said what it will charge commercially.

Last month, the Food and Drug Administration told vaccine manufacturers that their coronavirus vaccines for this fall should target XBB.1.5, though it is no longer the dominant strain, only making up 12.3 percent of all new COVID infections through the week ending July 22, according to the Centers for Disease Control and Prevention. 

The newly dominant strain is XBB.1.16, which accounts for about 15 percent of all new cases.

Previous Post

Leprosy could be endemic to the US. Here’s what to know

Next Post

Alabama infectious disease expert Jeanne Marrazzo tapped to replace Fauci

Next Post
Alabama infectious disease expert Jeanne Marrazzo tapped to replace Fauci

Alabama infectious disease expert Jeanne Marrazzo tapped to replace Fauci

  • Trending
  • Comments
  • Latest
Vaccine protection against COVID-19 related issues

Vaccine protection against COVID-19 related issues

April 26, 2022
2 in 3 physicians concerned about AI driving diagnosis, treatment decisions: Survey

2 in 3 physicians concerned about AI driving diagnosis, treatment decisions: Survey

October 31, 2023
Religious services may lower risk of ‘deaths of despair’

Religious services may lower risk of ‘deaths of despair’

April 26, 2022
Signaling molecule may prevent Alzheimer’s

Signaling molecule may prevent Alzheimer’s

April 26, 2022
Federal judge finds HHS mass layoffs likely unlawful

Federal judge finds HHS mass layoffs likely unlawful

0
7 Tips to Make Your Workout Routine More Sustainable

7 Tips to Make Your Workout Routine More Sustainable

0
11 Weight Loss Tips That Will Get you Fast Results

11 Weight Loss Tips That Will Get you Fast Results

0
What are the Sunday Scaries? Plus, Here’s How to Beat Them

What are the Sunday Scaries? Plus, Here’s How to Beat Them

0
Federal judge finds HHS mass layoffs likely unlawful

Federal judge finds HHS mass layoffs likely unlawful

July 1, 2025
Trump’s advice to ‘Alligator Alcatraz’ escapees: ‘Don’t run in a straight line’

Trump’s advice to ‘Alligator Alcatraz’ escapees: ‘Don’t run in a straight line’

July 1, 2025
Senate megabill marks biggest Medicaid cuts in history 

Senate megabill marks biggest Medicaid cuts in history 

July 1, 2025
Democratic states sue Trump administration over school mental health funding cuts

Democratic states sue Trump administration over school mental health funding cuts

July 1, 2025

Recent News

Federal judge finds HHS mass layoffs likely unlawful

Federal judge finds HHS mass layoffs likely unlawful

July 1, 2025
Trump’s advice to ‘Alligator Alcatraz’ escapees: ‘Don’t run in a straight line’

Trump’s advice to ‘Alligator Alcatraz’ escapees: ‘Don’t run in a straight line’

July 1, 2025
Senate megabill marks biggest Medicaid cuts in history 

Senate megabill marks biggest Medicaid cuts in history 

July 1, 2025
Democratic states sue Trump administration over school mental health funding cuts

Democratic states sue Trump administration over school mental health funding cuts

July 1, 2025
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Email Whitelisting
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Email Whitelisting

Disclaimer: Healthyfemalearmy.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized beauty advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give health advice or provide beauty recommendation. Any recommendations here should be taken into consideration only after consulting with your doctor.
© 2025 Healthyfemalearmy.com. All rights reserved.

No Result
View All Result
  • Contact Us
  • Email Whitelisting
  • Home 1
  • Privacy Policy
  • Terms and Conditions
  • Terms and Conditions

Disclaimer: Healthyfemalearmy.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized beauty advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give health advice or provide beauty recommendation. Any recommendations here should be taken into consideration only after consulting with your doctor.
© 2025 Healthyfemalearmy.com. All rights reserved.